Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience

BACKGROUND/AIM: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu’s arteritis (TA) patients who are unresponsive to corticosteroids ± conventional immunosuppressive agents. The aim of this study is to assess the efficacy and safety...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Turk J Med Sci
Main Authors: KILIÇ, Levent, KARADAĞ, Ömer, ERDEN, Abdulsamet, SARI, Alper, ARMAĞAN, Berkan, YARDIMCI, Gözde Kübra, FIRAT, Esra, KALYONCU, Umut, APRAŞ BİLGEN, Şule, KİRAZ, Sedat, ERTENLİ, İhsan, AKDOĞAN, Ali
Formato: Artigo
Idioma:Inglês
Publicado em: The Scientific and Technological Research Council of Turkey 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7080363/
https://ncbi.nlm.nih.gov/pubmed/31655524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3906/sag-1906-39
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados